Herbalife shares rose yesterday after billionaire Carl Icahn bought more than 2.3m shares in the nutrition company.

Spinmania is crossing the Atlantic. If 2014 was the year of the US corporate spinoff, the next 12 months may see the trend grow in Europe.

Allergan is not in active talks to acquire Salix Pharmaceuticals, people with knowledge of the matter said, though the drugmakers have discussed a deal.

Procter & Gamble, whose chief executive is under pressure from activist investor Bill Ackman, raised its 2013 profit forecast and posted quarterly earnings that beat analysts’ estimates after gaining market share in key categories.